FGF21 mediates alcohol-induced adipose tissue lipolysis by activation of systemic release of catecholamine in mice

Journal of Lipid Research

Volumn 56, Issue 8, 2015, Pages 1481-1491

  Zhao, Cuiqing ^a,b,c,d   Liu, Yanlong ^b,c,d   Xiao, Jian ^e   Liu, Liming ^b,c   Chen, Shaoyu ^c   Mohammadi, Moosa ^e   McClain, Craig J ^b,c,f   Li, Xiaokun ^a   Feng, Wenke ^b,c,d  

^a JILIN UNIVERSITY   (China)

^b Departments of Medicine and Pharmacology and Toxicology   (China)

^c University of Louisville School of Medicine   (United States)

^d WENZHOU MEDICAL UNIVERSITY   (China)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Adipose tissue; Alcoholic liver disease; Cell signaling; Fi broblast growth factor 21; Lipolysis and fatty acid metabolism; Liver

Indexed keywords

ALCOHOL; CATECHOLAMINE; CYCLIC AMP; FATTY ACID; FIBROBLAST GROWTH FACTOR 21; INSULIN; NORADRENALIN; FIBROBLAST GROWTH FACTOR;

ADIPOSE TISSUE; ALCOHOL CONSUMPTION; ALCOHOLIC FATTY LIVER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINGE DRINKING; CATECHOLAMINE RELEASE; CONTROLLED STUDY; ENZYME ACTIVATION; LIPOLYSIS; MALE; METABOLIC REGULATION; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SYMPATHETIC TONE; ANIMAL; C57BL MOUSE; DEFICIENCY; DRUG EFFECTS; EPIDIDYMIS; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; SECRETION (PROCESS); WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE; ADIPOSE TISSUE, WHITE; ANIMALS; BINGE DRINKING; CATECHOLAMINES; EPIDIDYMIS; ETHANOL; FATTY LIVER, ALCOHOLIC; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; HUMANS; INSULIN; LIPOLYSIS; MALE; MICE; MICE, INBRED C57BL; SIGNAL TRANSDUCTION;

EID: 84941279344     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M058610     Document Type: Article

References (58)

1. Raclot, T., and R. Groscolas. 1995. Selective mobilization of adipose tissue fatty acids during energy depletion in the rat. J. Lipid Res. 36 : 2164-2173.
2. Halliwell, K. J., B. A. Fielding, J. S. Samra, S. M. Humphreys, and K. N. Frayn. 1996. Release of individual fatty acids from human adipose tissue in vivo after an overnight fast. J. Lipid Res. 37 : 1842-1848.
3. Kang, L., X. Chen, B. M. Sebastian, B. T. Pratt, I. R. Bederman, J. C. Alexander, S. F. Previs, and L. E. Nagy. 2007. Chronic ethanol and triglyceride turnover in white adipose tissue in rats: inhibition of the anti-lipolytic action of insulin after chronic ethanol contributes to increased triglyceride degradation. J. Biol. Chem. 282 : 28465-28473.
4. Zhong, W., Y. Zhao, Y. Tang, X. Wei, X. Shi, W. Sun, X. Sun, X. Yin, X. Sun, S. Kim, et al. 2012. Chronic alcohol exposure stimulates adipose tissue lipolysis in mice: role of reverse triglyceride transport in the pathogenesis of alcoholic steatosis. Am. J. Pathol. 180 : 998-1007.
5. Dou, X., Y. Xia, J. Chen, Y. Qian, S. Li, X. Zhang, and Z. Song. 2014. Rectifi cation of impaired adipose tissue methylation status and lipolytic response contributes to hepatoprotective effect of betaine in a mouse model of alcoholic liver disease. Br. J. Pharmacol. 171 : 4073-4086.
6. Zhou, Z., L. Wang, Z. Song, J. T. Saari, C. J. McClain, and Y. J. Kang. 2005. Zinc supplementation prevents alcoholic liver injury in mice through attenuation of oxidative stress. Am. J. Pathol. 166 : 1681-1690.
7. Badman, M. K., A. Koester, J. S. Flier, A. Kharitonenkov, and E. Maratos-Flier. 2009. Fibroblast growth factor 21-defi cient mice demonstrate impaired adaptation to ketosis. Endocrinology. 150 : 4931-4940.
8. Kharitonenkov, A., T. L. Shiyanova, A. Koester, A. M. Ford, R. Micanovic, E. J. Galbreath, G. E. Sandusky, L. J. Hammond, J. S. Moyers, R. A. Owens, et al. 2005. FGF-21 as a novel metabolic regulator. J. Clin. Invest. 115 : 1627-1635.
9. Xu, J., D. J. Lloyd, C. Hale, S. Stanislaus, M. Chen, G. Sivits, S. Vonderfecht, R. Hecht, Y. S. Li, R. A. Lindberg, et al. 2009. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes. 58 : 250-259.
10. Inagaki, T., P. Dutchak, G. Zhao, X. Ding, L. Gautron, V. Parameswara, Y. Li, R. Goetz, M. Mohammadi, V. Esser, et al. 2007. Endocrine regulation of the fasting response by PPARalphamediated induction of fi broblast growth factor 21. Cell Metab. 5 : 415-425.
11. Arner, P., A. Pettersson, P. J. Mitchell, J. D. Dunbar, A. Kharitonenkov, and M. Ryden. 2008. FGF21 attenuates lipolysis in human adipocytes-a possible link to improved insulin sensitivity. FEBS Lett. 582 : 1725-1730.
12. Hotta, Y., H. Nakamura, M. Konishi, Y. Murata, H. Takagi, S. Matsumura, K. Inoue, T. Fushiki, and N. Itoh. 2009. Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver. Endocrinology. 150 : 4625-4633.
13. Potthoff, M. J., T. Inagaki, S. Satapati, X. Ding, T. He, R. Goetz, M. Mohammadi, B. N. Finck, D. J. Mangelsdorf, S. A. Kliewer, et al. 2009. FGF21 induces PGC-1 - and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response. Proc. Natl. Acad. Sci. USA. 106 : 10853-10858.
14. Wang, Y., I. Kirpich, Y. Liu, Z. Ma, S. Barve, C. J. McClain, and W. Feng. 2011. Lactobacillus rhamnosus GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury. Am. J. Pathol. 179 : 2866-2875.
15. Inagaki, T., V. Y. Lin, R. Goetz, M. Mohammadi, D. J. Mangelsdorf, and S. A. Kliewer. 2008. Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. Cell Metab. 8 : 77-83.
16. Plotnikov, A. N., S. R. Hubbard, J. Schlessinger, and M. Mohammadi. 2000. Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specifi city. Cell. 101 : 413-424.
17. Muise, E. S., B. Azzolina, D. W. Kuo, M. El-Sherbeini, Y. Tan, X. Yuan, J. Mu, J. R. Thompson, J. P. Berger, and K. K. Wong. 2008. Adipose fi broblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states. Mol. Pharmacol. 74 : 403-412.
18. Fern ández-Galilea, M., P. Pérez-Matute, P. L. Prieto-Hontoria, J. A. Martinez, and M. J. Moreno-Aliaga. 2012. Effects of lipoic acid on lipolysis in 3T3-L1 adipocytes. J. Lipid Res. 53 : 2296-2306.
19. Stumvoll, M., H. G. Wahl, K. Loblein, R. Becker, A. Volk, W. Renn, S. Jacob, and H. Haring. 2001. A novel use of the hyperinsulinemiceuglycemic clamp technique to estimate insulin sensitivity of systemic lipolysis. Horm. Metab. Res. 33: 89-95.
20. Prigge, W. F., and F. Grande. 1971. Effects of glucagon, epinephrine and insulin on in vitro lipolysis of adipose tissue from mammals and birds. Comp. Biochem. Physiol. B. 39 : 69-82.
21. Froesch, E. R., H. Burgi, P. Bally, and A. Labhart. 1965. Insulin inhibition of spontaneous adipose tissue lipolysis and effects upon fructose and glucose metabolism. Mol. Pharmacol. 1 : 280-296.
22. Goodridge, A. G., and E. G. Ball. 1965. Studies on the metabolism of adipose tissue. 18. In vitro effects of insulin, epinephrine andglucagon on lipolysis and glycolysis in pigeon adipose tissue. Comp. Biochem. Physiol. 16 : 367-381.
23. Lafontan, M., and M. Berlan. 1993. Fat cell adrenergic receptors and the control of white and brown fat cell function. J. Lipid Res. 34 : 1057-1091.
24. Lafontan, M. 1994. Differential recruitment and differential regulation by physiological amines of fat cell beta-1, beta-2 and beta-3 adrenergic receptors expressed in native fat cells and in transfected cell lines. Cell. Signal. 6 : 363-392.
25. Siler, S. Q., R. A. Neese, and M. K. Hellerstein. 1999. De novo lipogenesis, lipid kinetics, and whole-body lipid balances in humans after acute alcohol consumption. Am. J. Clin. Nutr. 70 : 928-936.
26. Ji, C., C. Chan, and N. Kaplowitz. 2006. Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model. J. Hepatol. 45 : 717-724.
27. Fiorenza, C. G., S. H. Chou, and C. S. Mantzoros. 2011. Lipodystrophy: pathophysiology and advances in treatment. Nat. Rev. Endocrinol. 7 : 137-150.
28. Kolditz, C. I., and D. Langin. 2010. Adipose tissue lipolysis. Curr. Opin. Clin. Nutr. Metab. Care. 13 : 377-381.
29. Miyoshi, H., S. C. Souza, H. H. Zhang, K. J. Strissel, M. A. Christoffolete, J. Kovsan, A. Rudich, F. B. Kraemer, A. C. Bianco, M. S. Obin, et al. 2006. Perilipin promotes hormone-sensitive lipasemediated adipocyte lipolysis via phosphorylation-dependent and-independent mechanisms. J. Biol. Chem. 281 : 15837-15844.
30. Londos, C., D. L. Brasaemle, C. J. Schultz, D. C. Adler-Wailes, D. M. Levin, A. R. Kimmel, and C. M. Rondinone. 1999. On the control of lipolysis in adipocytes. Ann. N. Y. Acad. Sci. 892 : 155-168.
31. Moore, H. P., R. B. Silver, E. P. Mottillo, D. A. Bernlohr, and J. G. Granneman. 2005. Perilipin targets a novel pool of lipid droplets for lipolytic attack by hormone-sensitive lipase. J. Biol. Chem. 280 : 43109-43120.
32. Holm, C. 2003. Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Biochem. Soc. Trans. 31 : 1120-1124.
33. Su, C. L., C. Sztalryd, J. A. Contreras, C. Holm, A. R. Kimmel, and C. Londos. 2003. Mutational analysis of the hormone-sensitive lipase translocation reaction in adipocytes. J. Biol. Chem. 278 : 43615-43619.
34. Haemmerle, G., A. Lass, R. Zimmermann, G. Gorkiewicz, C. Meyer, J. Rozman, G. Heldmaier, R. Maier, C. Theussl, S. Eder, et al. 2006. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science. 312 : 734-737.
35. Zimmermann, R., J. G. Strauss, G. Haemmerle, G. Schoiswohl, R. Birner-Gruenberger, M. Riederer, A. Lass, G. Neuberger, F. Eisenhaber, A. Hermetter, et al. 2004. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science. 306 : 1383-1386.
36. Miyoshi, H., J. W. Perfi eld II, S. C. Souza, W. J. Shen, H. H. Zhang, Z. S. Stancheva, F. B. Kraemer, M. S. Obin, and A. S. Greenberg. 2007. Control of adipose triglyceride lipase action by serine 517 of perilipin A globally regulates protein kinase A-stimulated lipolysis in adipocytes. J. Biol. Chem. 282 : 996-1002.
37. Bartness, T. J., Y. B. Shrestha, C. H. Vaughan, G. J. Schwartz, and C. K. Song. 2010. Sensory and sympathetic nervous system control of white adipose tissue lipolysis. Mol. Cell. Endocrinol. 318 : 34-43.
38. Large, V., O. Peroni, D. Letexier, H. Ray, and M. Beylot. 2004. Metabolism of lipids in human white adipocyte. Diabetes Metab. 30 : 294-309.
39. Crabb, D. W., A. Galli, M. Fischer, and M. You. 2004. Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha. Alcohol. 34 : 35-38.
40. Semba, R. D., K. Sun, J. M. Egan, C. Crasto, O. D. Carlson, and L. Ferrucci. 2012. Relationship of serum fi broblast growth factor 21 with abnormal glucose metabolism and insulin resistance: the Baltimore Longitudinal Study of Aging. J. Clin. Endocrinol. Metab. 97 : 1375-1382.
41. Dutchak, P. A., T. Katafuchi, A. L. Bookout, J. H. Choi, R. T. Yu, D. J. Mangelsdorf, and S. A. Kliewer. 2012. Fibroblast growth factor-21 regulates PPARgamma activity and the antidiabetic actions of thiazolidinediones. Cell. 148 : 556-567.
42. Kliewer, S. A., and D. J. Mangelsdorf. 2010. Fibroblast growth factor 21: from pharmacology to physiology. Am. J. Clin. Nutr. 91 : 254S-257S.
43. Camporez, J. P., F. R. Jornayvaz, M. C. Petersen, D. Pesta, B. A. Guigni, J. Serr, D. Zhang, M. Kahn, V. T. Samuel, M. J. Jurczak, et al. 2013. Cellular mechanisms by which FGF21 improves insulin sensitivity in male mice. Endocrinology. 154 : 3099-3109.
44. Lin, Z., H. Tian, K. S. Lam, S. Lin, R. C. Hoo, M. Konishi, N. Itoh, Y. Wang, S. R. Bornstein, A. Xu, et al. 2013. Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice. Cell Metab. 17 : 779-789.
45. Horning, M. G., E. A. Williams, H. M. Maling, and B. B. Brodie. 1960. Depot fat as source of increased liver triglycerides after ethanol. Biochem. Biophys. Res. Commun. 3 : 635-640.
46. Lee, R., R. Feinbaum, and V. Ambros. 2004. A short history of a short RNA. Cell. 116 : S89-S92.
47. Zouhal, H., C. Jacob, P. Delamarche, and A. Gratas-Delamarche. 2008. Catecholamines and the effects of exercise, training and gender. Sports Med. 38 : 401-423.
48. Frielle, T., S. Collins, K. W. Daniel, M. G. Caron, R. J. Lefkowitz, and B. K. Kobilka. 1987. Cloning of the cDNA for the human beta 1-adrenergic receptor. Proc. Natl. Acad. Sci. USA. 84 : 7920-7924.
49. Dixon, R. A., B. K. Kobilka, D. J. Strader, J. L. Benovic, H. G. Dohlman, T. Frielle, M. A. Bolanowski, C. D. Bennett, E. Rands, R. E. Diehl, et al. 1986. Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin. Nature. 321 : 75-79.
50. Emorine, L. J., S. Marullo, M. M. Briend-Sutren, G. Patey, K. Tate, C. Delavier-Klutchko, and A. D. Strosberg. 1989. Molecular characterization of the human beta 3-adrenergic receptor. Science. 245 : 1118-1121.
51. Lafontan, M. 2011. Kidney, adipose tissue, adipocytes-what's new [article in French]? Nephrol. Ther. 7 : 69-79.
52. Ireland, M. A., R. Vandongen, L. Davidson, L. J. Beilin, and I. L. Rouse. 1984. Acute effects of moderate alcohol consumption on blood pressure and plasma catecholamines. Clin. Sci. 66 : 643-648.
53. Jager, J., T. Gremeaux, T. Gonzalez, S. Bonnafous, C. Debard, M. Laville, H. Vidal, A. Tran, P. Gual, Y. Le Marchand-Brustel, et al. 2010. Tpl2 kinase is upregulated in adipose tissue in obesity and may mediate interleukin-1beta and tumor necrosis factor-{alpha} effects on extracellular signal-regulated kinase activation and lipolysis. Diabetes. 59 : 61-70.
54. Zhang, H. H., M. Halbleib, F. Ahmad, V. C. Manganiello, and A. S. Greenberg. 2002. Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes. 51 : 2929-2935.
55. Owen, B. M., X. Ding, D. A. Morgan, K. C. Coate, A. L. Bookout, K. Rahmouni, S. A. Kliewer, and D. J. Mangelsdorf. 2014. FGF21 acts centrally to induce sympathetic nerve activity, energy expenditure, and weight loss. Cell Metab. 20 : 670-677.
56. Badman, M. K., P. Pissios, A. R. Kennedy, G. Koukos, J. S. Flier, and E. Maratos-Flier. 2007. Hepatic fi broblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 5 : 426-437.
57. Kurosu, H., M. Choi, Y. Ogawa, A. S. Dickson, R. Goetz, A. V. Eliseenkova, M. Mohammadi, K. P. Rosenblatt, S. A. Kliewer, and M. Kuro-o. 2007. Tissue-specifi c expression of betaKlotho and fi-broblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. J. Biol. Chem. 282 : 26687-26695.
58. Tsukamoto, H., K. Machida, A. Dynnyk, and H. Mkrtchyan. 2009. "Second hit" models of alcoholic liver disease. Semin. Liver Dis. 29 : 178-187.